[
1. European Cancer Information System. https://ecis.jrc.ec.europa.eu/.
]Search in Google Scholar
[
2. Yang Y et al. A multicenter, retrospective epidemiologic survey of the clinical features and management of bone metastatic disease in China. Chin J Cancer. 2016; 35:40.10.1186/s40880-016-0102-6484538627112196
]Search in Google Scholar
[
3. Brufsky A, Mathew A. Bisphosphonates, bone, and breast cancer recurrence. Lancet. 2015; 386:1319-1320.10.1016/S0140-6736(15)61163-126211825
]Search in Google Scholar
[
4. Amin MB et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more ‘personalized’ approach to cancer staging. CA Cancer J Clin. 2017; 67:93-99.10.3322/caac.2138828094848
]Search in Google Scholar
[
5. Tobin NP et al. Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival. Ann Oncol. 2015; 26:81-88.10.1093/annonc/mdu498426934325361981
]Search in Google Scholar
[
6. Delpech Y et al. Clinical nomogram to predict bone-only metastasis in patients with early breast carcinoma. Br J Cancer. 2015; 113:1003-1009.10.1038/bjc.2015.308465112426393887
]Search in Google Scholar
[
7. Lee J-Y et al. MEL-18 loss mediates estrogen receptor–α downregulation and hormone independence. J Clin Invest. 2015; 125:1801-1814.10.1172/JCI73743446318825822021
]Search in Google Scholar
[
8. Cirstoiu M et al. Incidence and location of bone metastases in breast cancer. Romanian Journal of Orthopaedic Surgery and Traumatology. 2019; 2:28-31.10.2478/rojost-2019-0006
]Search in Google Scholar
[
9. Cîrstoiu M et al. A short-term retrospective analysis of the clinical, histopathological and immunohistochemical aspects of bone metastases. Romanian Journal of Orthopaedic Surgery and Traumatology. 2019; 2:84–90.10.2478/rojost-2019-0017
]Search in Google Scholar
[
10. Tahara RK, Brewer TM, Theriault RL, Ueno NT. Bone Metastasis of Breast Cancer. Adv Exp Med Biol. 2019; 1152:105-129.10.1007/978-3-030-20301-6_731456182
]Search in Google Scholar
[
11. Cummings MC et al. Metastatic progression of breast cancer: insights from 50 years of autopsies. J Pathol. 2014; 232:23-31.10.1002/path.4288428897424122263
]Search in Google Scholar
[
12. Coste A et al. Hematogenous Dissemination of Breast Cancer Cells From Lymph Nodes Is Mediated by Tumor MicroEnvironment of Metastasis Doorways. Front Oncol. 2020; 10: 571100.10.3389/fonc.2020.571100764936333194666
]Search in Google Scholar
[
13. Kang Y et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 2003; 3:537-549.10.1016/S1535-6108(03)00132-6
]Search in Google Scholar
[
14. Butt J, Botha M. Bone involvement in patients with cervical carcinoma: a single-institution cohort study. Southern African Journal of Gynaecological Oncology. 2019; 11:31-37.10.1080/20742835.2019.1702299
]Search in Google Scholar
[
15. Tiwari. Bone metastasis from ovarian cancer. https://www.cancerjournal.net/article.asp?issn=0973-1482;year=2007;volume=3;issue=1;spage=34;epage=36;aulast=Tiwari#ref5.10.4103/0973-1482.3196917998717
]Search in Google Scholar
[
16. Epidemiology, clinical presentation, and diagnosis of bone metastasis in adults - UpToDate. https://www.uptodate.com/contents/epidemiology-clinical-presentation-and-diagnosis-of-bone-metastasis-in-adults?search=breast%20cancer%20bone%20metastases%20screening&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#H2002102388.
]Search in Google Scholar
[
17. Schmidt GP et al. Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT. Eur Radiol. 2007; 17:939-949.10.1007/s00330-006-0361-816951929
]Search in Google Scholar
[
18. Guidelines Detail. NCCN https://www.nccn.org/guidelines/guidelines-detail.
]Search in Google Scholar
